Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01548885 · ClinicalTrials.gov registry record · NA
Comparison Evaluation of Blood Glucose Meter Systems
A NA study of Diabetes, sponsored by Ascensia Diabetes Care.
- Completed
- Registry status
- NA
- Development phase
- 146
- Enrollment target
- 1
- Study location
NCT01548885: Completed NA study of Diabetes, sponsored by Ascensia Diabetes Care.
NCT01548885 is a NA study of Diabetes that has completed, run by Ascensia Diabetes Care. The registered enrollment target is 146 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01548885, a NA study of Diabetes, has completed, sponsored by Ascensia Diabetes Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 146 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study was to evaluate the performance of one investigational Bayer Blood Glucose meter (with investigational Bayer test strips) and four Blood Glucose Monitoring Systems from other companies. All meter BG results were compared with plasma results obtained with a reference laboratory glucose method (YSI Glucose Analyzer). Performance of the five systems was evaluated across the glucose range of the BGMSs using capillary blood. All testing and lancing were performed by study staff and some blood samples were glycolyzed to lower the glucose levels.
Primary Outcome
Using the overall Blood Glucose(BG) range (24 to 386mg/dL), the Mean Absolute Relative Differences (MARD) between the BGM System readings and the YSI laboratory reference values were compared. MARD is calculated from the sum of all \|(BG meter)-(BG reference)\| / (BG Reference) assessments, divided by the number of assessments, then multiplied by 100(%). Each evaluable sample was tested on all five BGMS, thus the same number of BG test results was analyzed for each BGMS intervention. Lower MARD
Conditions Studied
Interventions
- DEVICE CONTOUR® NEXT EZ BGMS
- DEVICE FreeStyle Freedom Lite® BGMS
- DEVICE ACCU-CHEK® Aviva BGMS
- DEVICE TRUEtrack® BGMS
- DEVICE OneTouch® Ultra®2 BGMS
Study Locations (1)
Indiana
- Bayer HealthCare LLC, Diabetes Care - Mishawaka
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 146 participants |
| Start Date | 2012-03 |
| Est. Completion | 2012-03 |
| Phase | NA |
What the finished NCT01548885 record still lists
NCT01548885 is an interventional study that assigns participants to a tested intervention. The registered 146 participants enrollment target is mid-sized for trials with a published cap, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Diabetes appearing as the primary indexed condition, and to 5 interventions - of which CONTOUR® NEXT EZ BGMS is the first listed.
NCT01548885 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT01548885 about?
NCT01548885 is a clinical study titled "Comparison Evaluation of Blood Glucose Meter Systems". The purpose of this study was to evaluate the performance of one investigational Bayer Blood Glucose meter (with investigational Bayer test strips) and four Blood Glucose Monitoring Systems from other companies. All meter BG results were compared with plasma results obtained with a reference laborat...
What is the current status of trial NCT01548885?
This trial is currently completed. It is a NA study. The enrollment target is 146 participants. The study started on 2012-03. Estimated completion is 2012-03.
What conditions does trial NCT01548885 study?
This clinical trial studies the following conditions: Diabetes.
What interventions are being tested in trial NCT01548885?
The interventions under investigation include: CONTOUR® NEXT EZ BGMS (DEVICE), FreeStyle Freedom Lite® BGMS (DEVICE), ACCU-CHEK® Aviva BGMS (DEVICE), TRUEtrack® BGMS (DEVICE), OneTouch® Ultra®2 BGMS (DEVICE).
Who is sponsoring clinical trial NCT01548885?
This trial is sponsored by Ascensia Diabetes Care, which has 42 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01548885 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01548885's enrollment target sits among peer trials
146 172nd of 338 higher than 166 of 338 other Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of 2-Week Continuous Glucose Monitoring on Glycemic Management in Patients New-to-Insulin on Hospital Discharge
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
Efficacy of Viome's Precision Nutrition Program Towards Reducing HbA1c
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
-
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
RECRUITING · NA
-
Bringing Advocacy Via Digital Guide to the Emergency Department (Project BADGE)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03490929 · 146 participants · Phase 4
CEUS for Blunt Abdominal Trauma in Children
- NCT04755062 · 146 participants · NA
A Culturally-relevant Micronutrient-dense Plant-rich (mNDPR) Dietary Intervention for Native Americans
- NCT04867954 · 146 participants
Development of 4D Flow MRI for Risk Stratification of Variceal Bleeding in Cirrhosis
- NCT05051618 · 146 participants · NA
Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia